Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and Current Landscape
WIREs Nanomedicine and Nanobiotechnology · 2025-03 · 17 (2)
DOI: 10.1002/wnan.70010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 13.04.2025. Verfasst von Joan Castaneda Gonzalez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Arts and Sciences, Washington State University, Pullman, Washington, USA. Hauptthemen laut MEDLINE: Nucleic Acids, Nanoparticles, Gene Transfer Techniques. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Nucleic acid (NA) therapy holds tremendous potential for treating a wide range of genetic diseases by the delivery of therapeutic genes into target cells. However, significant challenges exist in safely and effectively delivering these genes to their intended locations. Viral vectors, though efficient, pose risks such as immunogenicity and mutagenesis. This has resulted in growing interest in non‐viral, nanoparticle‐based NA delivery systems. This review article describes various physiological barriers to NA delivery and explores nanoparticle‐based NA delivery systems, including bioengineered nanoparticles, peptides, lipid nanoparticles, and polymeric nanoparticles, highlighting their unique features to overcome in vivo barriers for NA delivery. While these nanoparticle‐based NA delivery systems offer a promising alternative to viral vectors, challenges related to cytotoxicity, reproducible synthesis, and cost need to be addressed. The current clinical landscape of NA delivery is also discussed, emphasizing the need for safer, scalable, and cost‐effective solutions. Nanoparticles represent a promising future in NA therapy, with the possibility of developing clinically relevant, non‐toxic, stable, and non‐immunogenic delivery vehicles, paving the way for broader therapeutic applications and improved clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Arts and Sciences, Washington State University, Pullman, Washington, USA.
- Department of Otolaryngology-Head & Neck Surgery Divisions, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Anjali Sharma
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Gonzalez, J. C., Park, K. W., Evans, D. B., Sharma, R., Sahaym, O., Gopalakrishnan, S., Dar, A. I., Valdez, T. A., & Sharma, A. (2025). Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and Current Landscape. WIREs Nanomedicine and Nanobiotechnology, 17(2). https://doi.org/10.1002/wnan.70010
Vancouver
Gonzalez JC, Park KW, Evans DB, Sharma R, Sahaym O, Gopalakrishnan S, et al. Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and Current Landscape. WIREs Nanomedicine and Nanobiotechnology. 2025;17(2). doi:10.1002/wnan.70010
BibTeX
@article{Gonzalez2025,
author = {Gonzalez, Joan Castaneda and Park, Ki Wan and Evans, Dallin Brian and Sharma, Rishi and Sahaym, Om and Gopalakrishnan, Shamila and Dar, Aqib Iqbal and Valdez, Tulio A and Sharma, Anjali},
title = {Nano Approaches to Nucleic Acid Delivery: Barriers, Solutions, and Current Landscape},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2025},
volume = {17},
number = {2},
doi = {10.1002/wnan.70010}
}
EUVIMED